Serina Therapeutics Inc SER Q1 2026 Earnings EPS Miss Amid Continued Development Progress CSWC Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Positive Sentiment DHCNI Q1 2026 Earnings Net Loss Misses Estimates Amid Challenging Environment Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses Western Copper and Gold WRN Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Development Stage JOE Q1 2026 Earnings EPS of 024 as Stock Edges Lower